BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16024997)

  • 1. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.
    Wente MN; Jain A; Kono E; Berberat PO; Giese T; Reber HA; Friess H; Büchler MW; Reiter RE; Hines OJ
    Pancreas; 2005 Aug; 31(2):119-25. PubMed ID: 16024997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of prostate stem cell antigen and Claudin-4 in human pancreatic carcinoma].
    Yagn WB; Cai F; Cheng CT; Cao G; Qin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Dec; 30(6):728-31. PubMed ID: 19180924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism.
    Gu Z; Yamashiro J; Kono E; Reiter RE
    Cancer Res; 2005 Oct; 65(20):9495-500. PubMed ID: 16230414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.
    Saffran DC; Raitano AB; Hubert RS; Witte ON; Reiter RE; Jakobovits A
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2658-63. PubMed ID: 11226295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
    Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK
    Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer.
    Foss CA; Fox JJ; Feldmann G; Maitra A; Iacobuzio-Donohue C; Kern SE; Hruban R; Pomper MG
    Mol Imaging; 2007; 6(2):131-9. PubMed ID: 17445507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.
    Argani P; Rosty C; Reiter RE; Wilentz RE; Murugesan SR; Leach SD; Ryu B; Skinner HG; Goggins M; Jaffee EM; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Cancer Res; 2001 Jun; 61(11):4320-4. PubMed ID: 11389052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.
    Reiter RE; Gu Z; Watabe T; Thomas G; Szigeti K; Davis E; Wahl M; Nisitani S; Yamashiro J; Le Beau MM; Loda M; Witte ON
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1735-40. PubMed ID: 9465086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRl of prostate cancer antigen expression for diagnosis and immunotherapy.
    Ren J; Wang F; Wei G; Yang Y; Liu Y; Wei M; Huan Y; Larson AC; Zhang Z
    PLoS One; 2012; 7(6):e38350. PubMed ID: 22761679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells.
    Morgenroth A; Cartellieri M; Schmitz M; Günes S; Weigle B; Bachmann M; Abken H; Rieber EP; Temme A
    Prostate; 2007 Jul; 67(10):1121-31. PubMed ID: 17492652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways.
    Marra E; Uva P; Viti V; Simonelli V; Dogliotti E; De Rinaldis E; Lahm A; La Monica N; Nicosia A; Ciliberto G; Palombo F
    BMC Cancer; 2010 Apr; 10():129. PubMed ID: 20374648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody.
    Olafsen T; Gu Z; Sherman MA; Leyton JV; Witkosky ME; Shively JE; Raubitschek AA; Morrison SL; Wu AM; Reiter RE
    J Immunother; 2007; 30(4):396-405. PubMed ID: 17457214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.
    Ross S; Spencer SD; Holcomb I; Tan C; Hongo J; Devaux B; Rangell L; Keller GA; Schow P; Steeves RM; Lutz RJ; Frantz G; Hillan K; Peale F; Tobin P; Eberhard D; Rubin MA; Lasky LA; Koeppen H
    Cancer Res; 2002 May; 62(9):2546-53. PubMed ID: 11980648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate stem cell antigen: a prospective therapeutic and diagnostic target.
    Raff AB; Gray A; Kast WM
    Cancer Lett; 2009 May; 277(2):126-32. PubMed ID: 18838214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression.
    Dubey P; Wu H; Reiter RE; Witte ON
    Cancer Res; 2001 Apr; 61(8):3256-61. PubMed ID: 11309275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate stem cell antigen: a Jekyll and Hyde molecule?
    Saeki N; Gu J; Yoshida T; Wu X
    Clin Cancer Res; 2010 Jul; 16(14):3533-8. PubMed ID: 20501618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.
    Gu Z; Thomas G; Yamashiro J; Shintaku IP; Dorey F; Raitano A; Witte ON; Said JW; Loda M; Reiter RE
    Oncogene; 2000 Mar; 19(10):1288-96. PubMed ID: 10713670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.
    Zettlitz KA; Tsai WK; Knowles SM; Kobayashi N; Donahue TR; Reiter RE; Wu AM
    J Nucl Med; 2018 Sep; 59(9):1398-1405. PubMed ID: 29602820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases.
    McCarthy DM; Maitra A; Argani P; Rader AE; Faigel DO; Van Heek NT; Hruban RH; Wilentz RE
    Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):238-43. PubMed ID: 12966350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.